Search Results

Orthofix Medical Inc today announced the appointment of Aviva McPherron as President of Global Operations and Quality.

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership with Aviva Systems Biology, a leading provider of antibody, protein, and immunoassay reagent products with an extensive portfolio of over 20,000 antibodies against more than 15,000 human gene targets.

Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new service offering for high throughput Antibody Characterization Services.

Cytokinetics, Incorporated announced that the Company will host the muscle biology-focused Contemporary Landscapes in Muscle Biology Research Symposium , May 17th, 2024 at the Mission Bay Conference Center in San Francisco.

As market values increase for computational biology and data science, biopharma companies are looking to hire R&D professionals in those areas. A biotech talent acquisition expert shares his insights on these in-demand roles.

Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced it has joined the YCharOS Industry Advisory Committee (IAC) which aims to enable users of antibodies to better evaluate commercially available antibody reagents.

Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced the launch of its new Protein on Demand™ semi-custom recombinant protein portfolio for life scientists conducting basic research and preclinical studies.